Impaired night-time mobility in patients with Parkinson’s disease: a systematic review

Impaired bed mobility (IBM) is a symptom characteristic of patients having difficulty intentionally moving their bodies during nighttime sleep. IBM is one of the most common nocturnal symptoms of Parkinson’s disease (PD) and may lead to extreme pain and even death; it also increases the burden on th...

Full description

Bibliographic Details
Main Authors: Shengyiwen Li, Qingyang Lin, Yannan Bao, Yichen Feng, Dianyou Li, Chencheng Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1264143/full
_version_ 1797488631765532672
author Shengyiwen Li
Shengyiwen Li
Qingyang Lin
Qingyang Lin
Yannan Bao
Yannan Bao
Yichen Feng
Dianyou Li
Dianyou Li
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
author_facet Shengyiwen Li
Shengyiwen Li
Qingyang Lin
Qingyang Lin
Yannan Bao
Yannan Bao
Yichen Feng
Dianyou Li
Dianyou Li
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
author_sort Shengyiwen Li
collection DOAJ
description Impaired bed mobility (IBM) is a symptom characteristic of patients having difficulty intentionally moving their bodies during nighttime sleep. IBM is one of the most common nocturnal symptoms of Parkinson’s disease (PD) and may lead to extreme pain and even death; it also increases the burden on the patients’ caregivers. In this systematic review, we included 19 studies involving a total of 1,407 patients with PD to observe the causes, assessment methods, and treatment options for IBM. We conclude that the extent of IBM is positively correlated with the severity of symptoms such as disease duration, dyskinesia and decreased sleep quality in patients with PD, and the evidence implies that IBM may be able to serve as a prodromal feature in the development of PD. IBM probably results from low nocturnal dopamine concentrations, reduced function of the spinal tract, torque problems in the muscles, and aging. Therefore, treatment is mostly based on continuously increasing the patient’s nocturnal dopamine concentration, while deep brain stimulation (DBS) also has a mitigating effect on IBM. Both scales and sensors are commonly used to measure the severity of IBM, the wearable device monitoring and scales being updated makes measurements easier and more accurate. The future of the advancement in this field lies in the use of more family-oriented devices (such as smart phones or watches and bracelets, etc.) to monitor IBM’s symptoms and select the appropriate therapeutic treatment according to the severity of the symptoms to relieve patients’ suffering.
first_indexed 2024-03-10T00:06:01Z
format Article
id doaj.art-2a7ae4570efd4df3ad1b0892dcd27543
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-03-10T00:06:01Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-2a7ae4570efd4df3ad1b0892dcd275432023-11-23T16:08:28ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652023-11-011510.3389/fnagi.2023.12641431264143Impaired night-time mobility in patients with Parkinson’s disease: a systematic reviewShengyiwen Li0Shengyiwen Li1Qingyang Lin2Qingyang Lin3Yannan Bao4Yannan Bao5Yichen Feng6Dianyou Li7Dianyou Li8Chencheng Zhang9Chencheng Zhang10Chencheng Zhang11Chencheng Zhang12Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Jiao Tong University School of Medicine, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Jiao Tong University School of Medicine, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Jiao Tong University School of Biomedical Engineering, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurosurgery, Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurosurgery, Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurosurgery, RuiJin-Mihoyo Laboratory, Clinical Neuroscience Center, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Research Center for Brain Science and Brain-Inspired Technology, Shanghai, ChinaImpaired bed mobility (IBM) is a symptom characteristic of patients having difficulty intentionally moving their bodies during nighttime sleep. IBM is one of the most common nocturnal symptoms of Parkinson’s disease (PD) and may lead to extreme pain and even death; it also increases the burden on the patients’ caregivers. In this systematic review, we included 19 studies involving a total of 1,407 patients with PD to observe the causes, assessment methods, and treatment options for IBM. We conclude that the extent of IBM is positively correlated with the severity of symptoms such as disease duration, dyskinesia and decreased sleep quality in patients with PD, and the evidence implies that IBM may be able to serve as a prodromal feature in the development of PD. IBM probably results from low nocturnal dopamine concentrations, reduced function of the spinal tract, torque problems in the muscles, and aging. Therefore, treatment is mostly based on continuously increasing the patient’s nocturnal dopamine concentration, while deep brain stimulation (DBS) also has a mitigating effect on IBM. Both scales and sensors are commonly used to measure the severity of IBM, the wearable device monitoring and scales being updated makes measurements easier and more accurate. The future of the advancement in this field lies in the use of more family-oriented devices (such as smart phones or watches and bracelets, etc.) to monitor IBM’s symptoms and select the appropriate therapeutic treatment according to the severity of the symptoms to relieve patients’ suffering.https://www.frontiersin.org/articles/10.3389/fnagi.2023.1264143/fullimpaired bed mobilitynocturnal hypokinesiaParkinson’s disease (PD)movement disordernocturnal akinesia
spellingShingle Shengyiwen Li
Shengyiwen Li
Qingyang Lin
Qingyang Lin
Yannan Bao
Yannan Bao
Yichen Feng
Dianyou Li
Dianyou Li
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
Chencheng Zhang
Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
Frontiers in Aging Neuroscience
impaired bed mobility
nocturnal hypokinesia
Parkinson’s disease (PD)
movement disorder
nocturnal akinesia
title Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
title_full Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
title_fullStr Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
title_full_unstemmed Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
title_short Impaired night-time mobility in patients with Parkinson’s disease: a systematic review
title_sort impaired night time mobility in patients with parkinson s disease a systematic review
topic impaired bed mobility
nocturnal hypokinesia
Parkinson’s disease (PD)
movement disorder
nocturnal akinesia
url https://www.frontiersin.org/articles/10.3389/fnagi.2023.1264143/full
work_keys_str_mv AT shengyiwenli impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT shengyiwenli impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT qingyanglin impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT qingyanglin impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT yannanbao impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT yannanbao impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT yichenfeng impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT dianyouli impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT dianyouli impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT chenchengzhang impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT chenchengzhang impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT chenchengzhang impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview
AT chenchengzhang impairednighttimemobilityinpatientswithparkinsonsdiseaseasystematicreview